Industry News

newsicon-industry

News from the global pharmaceuticals industry about head lice treatments and corporate developments, including takeovers and mergers.

16.03.17 | Randomised trials to assess the efficacy of Australian essential oils in the treatment of head lice

A new study has compared the efficacy of a head lice treatment containing Australian eucalyptus oil and Leptospermum petersonii (EO/LP Solution) with a neurotoxic treatment containing pyrethrins and piperonyl butoxide (P/PB Mousse) via a randomised controlled study.

16.09.16 | Efficacy of Abametapir Against Eggs of Human Head and Body Lice

A study undertaken to determine the ovicidal efficacy of abametapir against eggs of both human head and body lice has revealed that abametaphir has an 100% ovicidal activity in vitro assessments and therefore able to inhibit hatching of both head and body louse eggs if used in specific concetrations.

16.09.16 | Tyratech seeing continued growth of Vamousse

TyraTech has reported an increase of 31% in sales during the first half of 2016.

18.07.16 | Stubborn egg loosening lotion launched by Hedrin

The head lice brand Hedrin has announced the launch of a Stubborn Egg Loosening Lotion and suggested that this new addition to the Hedrin family would make it easy to remove dead eggs from the hair after treatment.

22.01.16 | Safety of Oral Ivermectin in Children

New commentary warns of the risks of excessive use of ivermectin for unauthorized groups.

14.09.15 | Xeglyze submitted for FDA approval, commercialisation deal announced

Hatchtech is submitting its Xeglyze lice treatment to the FDA for approval and has signed a commercialisation agreement with Dr. Reddy’s.

08.09.15 | Updated Pediculosis Pipeline insight report

DelveInsight have released an updated report covering the state of the pediculosis treatment pipeline.

28.08.15 | Eden Research license deal with TerpeneTech

Eden Research PLC has agreed a licensing deal with TerpeneTech Ltd granting exclusive use of its encapsulation technologies and other intellectual property for head lice treatments.

16.07.15 | Tyratech update: revenue and funding

Tyratech have announced increased revenues for 2014, and are focussing more of their funding on Vamousse.

15.06.15 | Lice Treatment Patent Infringement Complaint Filed

Larada Sciences Inc., a Utah-based head lice treatment company, have filed a complaint alleging patent infringement by Nitless Noggins, a California-based lice treatment company.

The patents concern methods for lice eradication via localised heat treatment, and are held by the University of Utah Research Federation, who have licensed them to Larada Sciences.

Larada Sciences developed AirAllé, a device for treating lice infection via heat treatment, which received FDA clearance in prior to its release with AirAllé branding in 2013.

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved